Repros Therapeutics Inc (RPRX)

[rstor1]

If an overseas trial expedites access to Europe, the value of RPRX is that much higher.

Is there a reason that you believe:

1. A trial conducted ex-US with FDA approved protocols will have more weight with the EMEA than one conducted in the US. (And we don't even know where ex-US is - may well be Asia)

2. There has been any kind of discussion with the Europeans about trials

3. Lacking any evidence of 1 and 2, it is worth the risk of a poorly run trial to curry favor on spec.

Bob